John Orloff - EVP, Alexion Pharmaceuticals, Inc

As of July 23, 2021


What is John Orloff's Net Worth?

The current estimated net worth of Alexion Pharmaceuticals, Inc's EVP, John Orloff, is estimated to be about $8.39M . John Orloff owns about 31,790 units of Alexion Pharmaceuticals, Inc common stock. In the last 4 years at Alexion Pharmaceuticals, Inc, John Orloff has sold an estimated value of $4.84M worth.

What is John Orloff's Past Insider Trading?

John Orloff's largest sale order was 2,115 units , worth over $250.69K on June 12, 2018. In total, John Orloff has made about 13 transactions over 4 years of their time at Alexion Pharmaceuticals, Inc. John Orloff usually trades in March and June, with the busiest year in 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was John Orloff's Salary in 2019?

As EVP of Alexion Pharmaceuticals, Inc, John Orloff has a total base salary of $770,000 . John Orloff received compensation valued at about $5,626,742 in 2019 after becoming EVP. The vast majority of their compensation came in the form of stock awards of $3,863,694 , other earnings, plans or compensations of $960,498 , and other compensation of $32,550 .

What is John Orloff's' Mailing Address?

  • Mailing address is C/o Baxalta Incorporated 1200 Lakeside Drive Bannockburn IL 60015 IL

Alexion Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ludwig Hantson 2019 $1,250,000 - $15,243,634 - $2,430,000 $24,350 $18,947,984
Ludwig Hantson 2018 $1,200,000 - $12,385,168 - $2,880,000 $25,082 $16,490,250
Ludwig Hantson 2017 $900,000 - $9,618,758 $2,282,881 $2,275,000 $233,428 $15,310,067
Aradhana Sarin 2019 $651,764 - $3,380,763 - $813,011 $31,604 $4,877,142
Paul Clancy 2019 $927,000 - $3,863,694 - $1,051,218 $23,832 $5,865,744
Paul Clancy 2018 $900,000 - $3,302,761 - $1,260,000 $23,752 $5,486,513
Paul Clancy 2017 $415,385 $500,000 $8,799,954 $1,220,082 $473,620 $2,262 $11,411,303
Brian Goff 2019 $740,000 - $3,863,694 - $923,076 $20,240 $5,547,010
Brian Goff 2018 $695,250 - $3,096,323 - $973,350 $111,873 $4,876,796
Brian Goff 2017 $381,634 $100,000 $2,390,026 $732,899 $434,380 $58,787 $4,097,726
Anne-Marie Law 2019 $695,000 - $3,622,303 - $788,130 $33,528 $5,138,961
Anne-Marie Law 2018 $650,000 - $2,889,885 - $910,000 $846,604 $5,296,489
Anne-Marie Law 2017 $362,500 $200,000 $2,300,015 - $410,472 $68,710 $3,341,697
John Orloff 2019 $770,000 - $3,863,694 - $960,498 $32,550 $5,626,742
John Orloff 2018 $695,250 - $3,096,323 - $973,350 $98,679 $4,863,602
John Orloff 2017 $376,442 $200,000 $2,499,995 - $472,500 $80,351 $3,629,288
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm

What are Alexion Pharmaceuticals, Inc's Past Insider Trades?

Alexion Pharmaceuticals, Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals, Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director,  Stephen Squinto, EVP,  and Vikas Sinha, EVP & CFO .

ALEXION PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1